Skip to main content
OpenTrials

Clinical trial condition

cMET Dysegulation Advanced Solid Tumors

Explore clinical trials studying cMET Dysegulation Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

cMET Dysegulation Advanced Solid Tumors trial results

Completed

A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.

NCT02925104

Conditions
cMET Dysegulation Advanced Solid Tumors
Locations
  • Indiana University Simon Cancer Center SC Indianapolis, Indiana, United States
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Herlev, Denmark
  • Novartis Investigative Site Dresden, Germany
View all 17 locations
View Trial Details